NCT04381650 2025-12-10A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Completed161 enrolled 44 charts
NCT01928394 2024-12-27A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid TumorsBristol-Myers SquibbPhase 1/2 Completed1,163 enrolled 33 charts 1 FDA
NCT02261532 2024-11-14A Phase I Study of TAS-102 in Solid TumorsTaiho Pharmaceutical Co., Ltd.Phase 1 Completed15 enrolled 7 charts